Healthcare Providers & Services
- 549.898
- +3.977+0.73%
Extendicare Price Target Raised to $8.50 at RBC
WELL Health Maintained at Buy at Stifel GMP as It Buys 10 Clinics From Shoppers Drug Mart; Price Target Kept at C$11.00
Extendicare Price Target Raised to $8 at RBC
Kneat.com Maintained at Buy at Stifel GMP After Q4 Results; Price Target Raised to C$4.15
Kneat.com Maintained at Buy at Stifel GMP Following Bought-Deal Offering; Price Target Raised to C$4.00
WELL Health Technologies Initiated at Outperform, $5.50 Price Target at RBC
WELL Health Technologies Corp (WELL) Gets a Buy Rating From Stifel Nicolaus
Kneat.com (KSI) Receives a Buy From Stifel Nicolaus
Stifel Nicolaus Sticks to Its Buy Rating for WELL Health Technologies Corp (WELL)
Laurentian Bank of Canada Maintains Their Buy Rating on WELL Health Technologies Corp (WELL)
WELL Health Technologies Corp (WELL) Gets a Buy Rating From TD Securities
WELL Health Technologies Corp (WELL) Receives a Buy From Echelon Wealth Partners
Stifel Nicolaus Sticks to Its Buy Rating for WELL Health Technologies Corp (WELL)
Kneat.com (KSI) Receives a Buy From Stifel Nicolaus
Kneat.com (KSI) Gets a Buy Rating From Echelon Wealth Partners
WELL Health Technologies Corp (WELL) Gets a Buy Rating From Echelon Wealth Partners
Echelon Wealth Partners Remains a Buy on CareRx (CRRX)
WELL Health Technologies Corp (WELL) Receives a Buy From Stifel Nicolaus
Echelon Wealth Partners Keeps Their Buy Rating on WELL Health Technologies Corp (WELL)
Echelon Wealth Partners Keeps a Buy Rating on Kneat.com (KSI)